1. Introduction {#s0005}
===============

Genetic analysis is a part of molecular biology specifically concerned with the understanding of the information which is encrypted in genes that are necessary for growth, reproduction and evolution of living organisms. Genes are some regions of the DNA (Deoxyribose Nucleic Acid) or RNA (Ribose Nucleic Acid) and act as a collection of biological information which is necessary to build and maintain an organism's cells [@b0005]. Genetic analysis includes molecular technologies such as DNA sequencing, DNA microarrays, cytogenetic and Polymerase Chain Reaction (PCR).

Due to the proliferation of DNA microarray technology, it is now possible to generate gene expressions and analyse expression patterns of several genes in a systematic and comprehensive manner [@b0010]. Microarrays help in detecting messenger RNA (mRNA) (which convey genetic information from DNA). Since it has tens of thousands of probes hence it can accomplish many genetic tests in parallel [@b0015]. Using microarray technology, relative expression levels for genes are computed. The result of the computation forms the gene expression dataset [@b0020], [@b0025].

We need to find gene-gene network modules which are a collection of genes that are functionally similar. Traditional machine learning [@b0030] and statistical methods rely on disease-identification markers to support appropriate analysis of a disease. However, it has been shown that genes are usually involved in more than one function, and it is the interplay among genes that lead to diseases like cancer [@b0035].

In order to find semantic similarities between a pair of genes from a dataset, a gene-gene network, referred here as the Gene Co-Expression Network (GCEN) has been constructed. It is a graph where each node represents a gene and an edge between two nodes represents either the interaction or some other relationship [@b0040], [@b0045], [@b0050], [@b0055].

Next, a module extraction technique has been introduced, which enables to extract 'modules' from a GCEN. A module is a set of genes forming a dense region in the co-expression network. In other words, the modules are network components containing highly-correlated genes. Genes with high correlation correspond to some common biological phenomenon. By choosing the appropriate gene expression dataset and constructing efficient GCEN, module extraction can help to determine what genes are responsible for a biological process, like the progression a disease [@b0060], [@b0065] or a common phenomenon like metabolism.

The major contributions of this paper are as follows.•A fast method for construction and analysis of GCEN implemented on GPU.•An effective network module extraction technique to support biomarker identification for a given disease. Here, we consider breast cancer, as an example disease.•Six interesting genes have been identified w.r.t the ten causal genes of breast cancer for homo-sapiens.•Some interesting topological associations have also been identified among these six biomarkers across the non-metastasis and metastasis stages.

The rest of the paper is organized as follows: Section [2](#s0010){ref-type="sec"} provides a discussion on some relevant literature. Section [3](#s0015){ref-type="sec"} reports the proposed method, i.e., PNME, whereas in Section [4.1](#s0025){ref-type="sec"} the implementation of PNME and some interesting results are reported. The concluding remarks are given in Section [4.2.1](#s0035){ref-type="sec"}.

2. Related work {#s0010}
===============

In literature, a number of techniques have been proposed for gene co-expression network construction. When inferring co-expression networks from gene expression data, a gene expression dataset is taken as primary input and then by using correlation-based proximity measures, the corresponding co-expression network is constructed. Frequently used correlation-based measures are Pearson Correlation Coefficient (PCC) and Spearman Correlation Coefficient (SCC). Approaches reported in [@b0040] use PCC to extract the association among genes in a co-expression network.

The use of Generalized Topological Overlap Measure (GTOM) as a (dis) similarity measure has been reported in [@b0070]. It has also been established that the original TOM mentioned in [@b0075] discovers smaller modules, and higher order GTOM mentioned in [@b0070] can help discovers larger modules. The implementation of GTOM in GPU makes use of the Strassen's Matrix Multiplication algorithm, implementation of which is described in [@b0080]. The algorithm was implemented using the CUBLAS library of the CUDA platform, documentation of which can be found in [@b0085].

Multiple ways of defining gene modules have been proposed in literature [@b0050], [@b0045], [@b0070]. For detection of biologically meaningful modules, the generalized TOM measure (GTOM) [@b0070] has been found very effective [@b0090]. The study of the significance of module detection and extraction in revealing genes that are essential for biological phenomena has been explored in [@b0095]. Several methods of choosing a correlation threshold to arrive at a network exist. A strategy based on statistical significance has been reported in [@b0070], [@b0050] and also the authors highlight the limitations.

Implementation of GTOM requires massive matrix operations, especially when large datasets [@b0100] are used. The use of GPU in such applications has been justified in [@b0105]. Programming the GPU requires the use of the CUDA platform. The features, advantages, usage of CUDA have been discussed in [@b0110] and in [@b0115]. Further applications of CUDA and GPU, in general, are discussed in [@b0115]. For parallel vector/matrix operations on the GPU, CUDA provides the CUBLAS library containing data structures, algorithms and functions for handling and processing large vectors and matrices. The implementation of Strassen Multiplication Algorithm in CUBLAS library has been analyzed and discussed in [@b0120]. Finally, the documentation for CUDA [@b0115], [@b0125] and CUBLAS [@b0085] describes the data structures and operations in detail, including operations for transferring data to and from the GPU. Finally, the biological significance of module extraction and scope for further applications is reviewed in [@b0075], [@b0050], [@b0090].

Although in the past decade a good number of network module extraction techniques have been evolved to support gene-gene network analysis, still it demands an effective technique which can fulfil the following requirements.•ability to handle voluminous gene expression data instances,•ability to handle gene expression data with high dimensionality,•ability to extract module(s) of high biological significances, and•ability to provide response quicker.

3. PNME: The proposed framework for network construction and module extraction {#s0015}
==============================================================================

Biological Networks are useful for understanding gene-gene association and other functional properties of genes [@b0130], [@b0135], [@b0140]. The commonly used biological networks include protein-protein interactions, signalling networks, metabolic networks, gene regulatory networks and GCEN. Gene co-expression networks have coverage of nearly all human genes, including cancer-related genes [@b0145].

We define gene expression data as *G* = $\{ G_{1},G_{2},\ldots,G_{m}\}$ be a set of *m* genes and *R* = $\{ T_{1},T_{2},\ldots,T_{n}\}$ be the set of *n* conditions or time points of a gene expression dataset. The gene expression dataset *X* can be represented as a matrix of order $m \times n$ i.e., $X_{\mathit{mn}}$ where each entry $X(i,j)$ in the matrix corresponds to the logarithm of the relative abundance of mRNA of a gene.

Co-expression network is an undirected graph where genes are nodes of the graph. Two nodes (genes) are connected if their activities have a significant association with a series of gene expression measurements. This association can be computed using a suitable correlation measure like Pearson, Kendall or Spearman. We use the Pearson Correlation Coefficient (PCC) to obtain the correlation as a matrix *C*. Each element $C_{\mathit{ij}}$ of the matrix corresponds to the similarity between expression values of two genes $G_{i}$ and $G_{j}$. PCC handles both negative and positive correlations, the value computed varies between +1 and −1. The Pearson Correlation between $G_{1}$ and $G_{2}$ over a Dataset *D* is represented by *r*($G_{i},G_{j}$) and defined by Eq. [(1)](#e0005){ref-type="disp-formula"}$$r(G_{i},G_{j}) = \frac{n\sum G_{i}G_{j} - \sum G_{i}\sum G_{j}}{\sqrt{n(\sum G_{i}^{2}) - {(\sum G_{i})}^{2}}\sqrt{n(\sum G_{j}^{2}) - {(\sum G_{j})}^{2}}}$$

For each similarity value between a pair of genes with a given threshold (support count), we compute 0--1 adjacency matrix as a representation of a graph. This graph represents the co-expression network.Algorithm 1Algorithm for constructing CEN ![](fx1.gif)

Next, PNME extracts highly correlated network modules from *G* using GTOM. GTOM helps to find highest non-overlapping pairs of genes. It acts as a similarity measure which has been found useful in biological networks [@b0070].

A network module $C_{i}$ is defined as a set of genes forming a dense region in the co-expression network, with GTOM $\in$ *any top n GTOM values* corresponding to the extracted network modules [@b0070]. GTOM is defined as following:$$w_{\mathit{ij}} = \frac{l_{\mathit{ij}} + a_{\mathit{ij}}}{\mathit{\min}(k_{i},k_{j}) + 1 - a_{\mathit{ij}}}$$where $l_{\mathit{ij}} = \sum_{u}a_{\mathit{iu}}a_{\mathit{ij}}$, and $k_{i} = \sum_{u}a_{\mathit{iu}}$ is the node connectivity. Basically, $w_{\mathit{ij}}$ is an indicator for the agreement between the sets of neighboring nodes of *i* and *j*. The inclusion of the term $a_{\mathit{ij}}$ in the numerator makes $w_{\mathit{ij}}$ explicitly dependent on whether there is a direct link between the two nodes in question. The purpose of the quantity $1 - a_{\mathit{ij}}$ in the denominator is to avoid double-counting *i* as a neighbour of *j* and vice versa.Algorithm 2Algorithm for Module Extraction ![](fx2.gif)

4. Implementation and results {#s0020}
=============================

A general purpose GPU (GPGPU) pipeline is a form of parallel processing between one or more GPUs and CPUs that analyzes data as if it were two-dimensional or three-dimensional, like an image or texture. GPUs have large cores that operate at lower frequencies, hence suitable for applications having small parallel units. Though, there is a limitation on parallel processing of application as it offloads compute-intensive portions of the application to the GPU, while the remainder of the code still runs on the CPU. CUDA is a parallel programming platform that allows programmers to use CUDA-enabled GPUs for general purpose processing [@b0125]. CUDA exposes a software model and an API that gives direct access to the GPUs instruction set and computation elements for the execution of programs (compute kernels).

In this work, PCC measure has been implemented using GPGPU platform. Each thread of the GPU processes two rows of the data matrix at a time to compute arithmetic mean towards finding correlation between the pair based on PCC. Each thread accesses a single location in a 2D array to store the computed PCC value represented by the 2D indices of the array corresponding to the gene id's of the rows it is processing.

Before storing the value in the array, a threshold $\Theta$ is applied.$$\mathit{pcc}(i,j) = \left\{ \begin{array}{ll}
0 & {\text{if}\mspace{6mu} r(G_{i},G_{j}) \leqslant \Theta} \\
1 & {\text{if}\mspace{6mu} r(G_{i},G_{j}) \geqslant \Theta} \\
\end{array} \right)$$The final matrix of the order $m \times m$ (*m* being the No. of genes, or the No. of rows in the dataset) can now be treated as an adjacency matrix representing an undirected graph. Note that the following properties must hold for the graph to be undirected.•$\mathit{pcc}(i,j) = \mathit{pcc}(j,i)$•$\mathit{pcc}(i,i) = 0$

If two expressions are the same, they must be fully correlated (positively). However, for representation of the undirected graph, we set it to zero.

We cannot have a parallel implementation of GTOM from the definition given above. A parallel method of computing GTOM has been proposed by [@b0070]. We use this method to implement GTOM algorithm in GPU.

The co-expression network *C* obtained in the previous step is stored as a matrix. In order to calculate GTOMm for a given value m, we need to multiply the matrices in the GPU to obtain $A^{2},A^{3},A^{4},\ldots,A^{m}$. We compute each of the $A^{i}$ for all $i = \{ 1,2,\ldots,m\}$. Our algorithm computes $A^{i}$ by multiplying *A* and $A^{i - 1}$, thus requiring *m* calls to the $\text{cublasSgemm}()$ function. The intermediate results are stored in an array of matrices which are added then normalized to obtain the matrix *G*.$$\mathit{GTOMm}(i,j) = \left\{ \begin{array}{ll}
0 & {\text{if}\mspace{6mu} G(i,j) \leqslant \Phi} \\
1 & {\text{if}\mspace{6mu} G(i,j) \geqslant \Phi} \\
\end{array} \right)$$

After normalization, we apply a threshold $\Phi$ to convert *G* into a network. Modules can be extracted by simply identifying the connected components in the network. These modules are sub-graphs where each node again corresponds to a gene. The connected components are extracted from the GTOMm network and stored in a file (as edge-lists) for analysis.

4.1. Dataset used {#s0025}
-----------------

We performed our experimentation on *GSE2034* dataset, a Breast Cancer Relapse Free Survival Microarray Dataset [@b0150], [@b0095], [@b0025]:•**Title:** Breast Cancer Relapse Free Survival (GSE2034)•**Organism:** Homo Sapiens•**Experiment type:** Expression profiling by array

This dataset represents 180 lymph-node negative relapse-free patients (non-metastasis) and 106 lymph-node negative patients that developed a distant metastasis, for a total of 22,283 genes [@b0150]. We use *log2* transformation in order to scale the values, and variance of 1.2 to select 5292 genes [@b0035].

4.2. Results and observations {#s0030}
-----------------------------

PNME has been implemented in Python 3.6 and C and tested on CentOS 6.5 (Linux Kernel 2.6.32-431) on a Dell T7910 with 2 Intel Xeon-Phi Co-processors, 64 GB RAM, 8 TB storage and 2 NVIDIA Tesla K40 GPUs.

In our experimentation, two thresholds have been used at two different points of analysis. One threshold is the PCC threshold $\theta$ used for computing correlation between two genes' expression series. The other threshold is the GTOMm threshold $\Phi$ used during extraction of modules from the GTOMm graphs. Also, before computing the GTOMm matrix, the parameter *m* (*m* is number of iteration of GTOM) has to be set.

We derive $\Theta,\mspace{6mu}\Phi$ and *m* from the following sets. These values (set elements) have been decided through exhaustive experimentation.•$\Theta = \{ 0.45,0.53,0.65,0.75\}$•$\Phi = \{ 0.4,0.5,0.6,0.7,\}$•$m = \{ 1,2,3,4\}$

For given values of $\Theta,\Phi$ and *m*, 128 network modules have been generated for analysis. To choose the best value among them we compute p-value and q-value of each network module. A p-value is a probability for a set of genes to be improved with the same functional group [@b0035]. A q-value is an adjusted p-value for False Discovery Rate(FDR). The p-value for a module M enriched with functional group F is given as:$$p\text{-}\mathit{value} = 1 - \sum\limits_{i = 0}^{q - 1}\frac{\begin{pmatrix}
{|F|} \\
i \\
\end{pmatrix}\begin{pmatrix}
{|V| - |F|} \\
{|M| - i} \\
\end{pmatrix}}{\begin{pmatrix}
{|V|} \\
{|F|} \\
\end{pmatrix}}$$

In order to choose the best values for parameters $\Phi,\mspace{6mu}\Theta$ and *m*, the p-value for each module is computed for the values of parameters from the sets defined above. The results are given in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}. Our observation is that the best p-value is obtained for $\Theta = 0.45,\mspace{6mu}\Phi = 0.4$ and $m = 3$ (GTOM3). The lowest p-value signifies modules that are most biologically-similar amongst themselves.Table 1p-Values and q-values for tests on Metastasis for GTOM1.$\Theta$ ↓p-Value with $\Phi$q-Value with $\Phi$$\Phi = 0.4$$\Phi = 0.5$$\Phi = 0.6$$\Phi = 0.7$$\Phi = 0.4$$\Phi = 0.5$$\Phi = 0.6$$\Phi = 0.7$$0.45$1.26E−51.04E−42.05E−42.3E−55.0E−28.3E−21.9E−22.2E−2$0.53$2.74E−41.73E−41.75E−42.67E−41.1E−11.51E−11.5E−11.6E−1$0.65$2.1E−42.9E−49.4E−42.14E−41.85E−11.4E−11.64E−11.18E−1$0.75$6.4E−42.5E−43.13E−47.2E−41.5E−11.20E−18.67E−28.6E−2Table 2p-Values and q-values for tests on Non-metastasis for GTOM1.$\Theta$ ↓p-value with $\Phi$q-value with $\Phi$$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$0.45$8.4E−72.04E−54.3E−58.5E−48.5E−42.37E−27.07E−27.6E−2$0.53$1.75E−58.6E−51.31E−48.63E−52.3E−27.7E−26.7E−27.8E−2$0.65$9.4E−51.50E−51.7E−45.5E−41.0E−11.37E−25.6E−23.54E−2$0.75$1.67E−31.04E−33.7E−42.81E−41.74E−11.53E−11.2E−17.93E−2Table 3p-Values and q-values for tests on Metastasis for GTOM2.$\Theta$ ↓p-value with $\Phi$q-value with $\Phi$$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$0.45$9.31E−82.48E−61.85E−52.85E−65.0E−54.1E−33.67E−24.52E−3$0.53$2.6E−54.6E−51.52E−55.44E−64.4E−24.8E−22.41E−27.1E−3$0.65$2.67E−62.72E−57.49E−53.33E−45.02E−32.4E−21.07E−11.38E−1$0.75$1.7E−41.55E−31.04E−33.91E−41.10E−11.07E−18.9E−27.63E−2Table 4p-Values and q-values for tests on Non-Metastasis for GTOM2.$\Theta$ ↓p-value with $\Phi$q-value with $\Phi$$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$\Phi$ = 0.4$\Phi$ = 0.5$\Phi$ = 0.6$\Phi$ = 0.7$0.45$8.7E−141.8E−122.0E−83.9E−63.9E−103.2E−105.3E−58.75E−3$0.53$9.3E−92.2E−61.2E−49.9E−52.5E−55.2E−34.2E−24.8E−2$0.65$4.9E−53.7E−59.2E−61.6E−43.8E−25.5E−21.19E−26.39E−2$0.75$2.2E−31.66E−67.7E−31.82E−21.82E−16.4E−49.8E−21.4E−1

[Table 1](#t0005){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 5](#t0025){ref-type="table"} reports p-values and q-values for metastasis corresponding to GTOM1, GTOM2 and GTOM3, respectively and [Table 2](#t0010){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 6](#t0030){ref-type="table"} report p-values and q-values of non-metastasis corresponding to GTOM1, GTOM2 and GTOM3, respectively and with different parameters (see [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}).Table 5p-Values and q-values for tests on Metastasis for GTOM3.$\Theta$ ↓P-value with $\Phi$Q-value with $\Phi$$\Phi$ = 0.4$\Phi$ =  0.5$\Phi$ =  0.6$\Phi$ =  0.7$\Phi$ =  0.4$\Phi$ =  0.5$\Phi$ =  0.6$\Phi$ = 0.7$0.45$1.9E−71.1E−64.22E−65.9E−65.2E−42.46E−37.7E−38.58E−3$0.53$6.8E−51.6E−54.4E−69.8E−75.1E−22.8E−26.21E−31.08E−3$0.65$3.6E−537.4E−59.2E−51.54E−42.2E−21.06E−16.8E−29.8E−2$0.75$1.71E−31.7E−48.1E−43.9E−41.1E−11.1E−18.98E−27.63E−2Table 6p-Values and q-values for tests on Non-Metastasis for GTOM3.$\Theta$ ↓P-value with $\Phi$Q-value with $\Phi$$\Phi$ = 0.4$\Phi$ =  0.5$\Phi$ =  0.6$\Phi$ =  0.7$\Phi$ =  0.4$\Phi$ =  0.5$\Phi$ =  0.6$\Phi$ = 0.7$0.45$8.5E−123.5E−82.2E−61.09E−52.6E−89.4E−52.84E−32.03E−2$0.53$1.2E−68.58E−67.8E−54.10E−53.02E−31.42E−23.8E−23.5E−2$0.65$9.8E−43.4E−33.4E−31.1E−41.1E−19.6E−26.7E−24.91E−2$0.75$7.54E−465E−31.09E−22.16E−21.1E−11.05E−19.4E−21.44E−1Fig. 1Conceptual framework for parallel gene-gene network module extraction.Fig. 2Variation of degrees of each casual gene in each stage.

### 4.2.1. Observations {#s0035}

We obtain a correlated and highly connected co-expression network with $\Theta = 0.45$ and $\Phi = 0.4$ in both metastasis and non-metastasis stage as shown in [Fig. 3](#f0015){ref-type="fig"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}. From the network, 180 genes have been found to participate both in metastasis and non-metastasis phase of cancer. Out of these 180 genes, we identify 10 causal genes which participate in breast cancer as per Malacard's [@b0155] database. Using each of these 10 causal genes as primary genes, we identify some secondary set of genes, not present in Malacards, but are highly associated with the primary gene.Fig. 3Figure (a): highly connected genes in Non-Metastasis Stage, figure (b): highly connected genes in Metastasis Stage.Fig. 4Network between 10 primary and 6 secondary genes on (a) non-metastasis stage and (b) metastasis stage.

Next, each secondary gene is verified whether it follows the common genetic pathway with the primary genes or not. In order to do this, the online tool DAVID [@b0160], [@b0165], [@b0170] has been used. The results are shown in [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"} and [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"}).Fig. 5Computation time for different *GTOM*m (m from 1 to 4) in GPU and CPU.Fig. 6Pathways in cancer of secondary genes in Non-metastasis. The above figure is generated using genemania \[<https://genemania.org/>\] [@b0220].Table 7Secondary genes following same pathways as primary genes in Non-metastasis stage.Non-Metastasis stagePrimary Genes(P)Degree(Dp)Seconday Genes(S)Degree(Ds)KEGG PathwaysCDH155TRAF418Pathways in cancerCDH155FH11Pathways in cancerPAK130RASGRP152T cell receptor signaling pathwayPAK130LAMA439Focal adhesionFGFR225PDGFRA50Pathways in cancerNRP122EPHB348Axon guidanceCASP818BIRC339Pathways in cancerTable 8Secondary genes following same pathways as primary genes in metastasis stage.Metastasis stagePrimary Genes(P)Degree(Dp)Secondary Genes(S)Degree(Ds)KEGG PathwaysCDH141FH7Pathways in cancerPAK125RASGRP135T-cell Receptor Signalling PathwayPAK125LAMA425Focal adhesionEGFR19FAS18Pathways in cancerNRP115EPHB340Axon guidance

### 4.2.2. Significance of secondary genes in Breast Cancer {#s0040}

In this section, six interesting genes(referred here as secondary genes) are reported which have been found to have close associations with those 10 causal genes(as available in Gene malacards [@b0155]) both topologically as well as behaviorally. From the selected literature survey, it has been observed that all these six genes have significant roles in causing or driving breast cancer metastasis in homo sapiens (see [Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}).**(a) TRAF4**Tumor Necrosis Factor Receptor-associated Factor 4 (TRAF4) plays an important role in tumorigenesis of breast cancer [@b0175]. It drives breast cancer metastasis [@b0180].**(b) LAMA4**Laminin Subunit Alpha 4 (LAMA4) expressions are high in breast cancer patients with worse relapse-free survival and low LAMA4 in patients with improved relapse-free survival. Also, malignant breast cancer cells express higher levels of LAMA4 relative to pre-malignant cells [@b0185].**(c) FAS**Fas cell surface death receptor (FAS) shows significant associations with an increasing risk of breast cancer [@b0190]. It has been observed that the risk of breast cancer may be elevated among women with polymorphisms in the FAS gene [@b0195].**(d) PDGFRA**Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) has been found as being uniquely expressed and active in inflammatory breast cancer (IBC) patient tumor cells and may be a promising target for therapy in IBC [@b0200]. PDGFRA activation signature is also associated with small metastasis-free survival.**(e) BIRC3**BIRC3 is involved in chemo-resistance to doxorubicin in breast cancer cells [@b0205]. As per the human protein atlas [@b0210], BIRC3 is favourable for breast cancer.**(f) EPHB3**The largest family member of receptor tyrosine kinases, EPH receptors regulates cancer initiation and metastatic progression. Eph's expression is often elevated in breast cancer [@b0215].Fig. 7Pathways in cancer of secondary genes in metastasis.The above figure is generated using genemania \[<https://genemania.org/>\] [@b0220].

### 4.2.3. Association among primary and secondary genes {#s0045}

Another experimental topological study has been carried out to understand the associations among the primary and secondary genes across the two conditions (i.e., from non-metastasis to metastasis). It is aimed to understand the existence of the secondary genes (isolated or co-occurred) w.r.t. the primary genes across these two conditions. [Fig. 4](#f0020){ref-type="fig"} and [Table 9](#t0045){ref-type="table"} report the topological behaviour. Some interesting observations are enumerated below.(a)Two highly correlated secondary genes namely, TRAF4 and BIRC3 in the non-metastasis stage, have been found no association among other genes, during metastasis stage.(b)FAS has been found to be highly associated with other genes in metastasis, while it was found missing in the non-metastasis stage.(c)LAMA4 and PDGFRA are weakly associated with both the stage and their degrees of an association have become weaker in metastasis stage.(d)EPHB3 shows the highest degree of association among all other secondary genes in the non-metastasis stage, have also been found to be associated with others strongly in metastasis stage.Table 9Degree of each secondary genes on network made from 10 primary and 6 secondary genes.Non-metastasisMetastasisGene namesDegreeGene namesDegeeTRAF46TRAF4--LAMA44LAMA43FAS--FAS5PDGFRA1PDGFRA--BIRC35BIRC3--EPHB37EPHB38

### 4.2.4. Time computation {#s0050}

The algorithm for construction of the co-expression network has time complexity $O(n^{2}m)$, where *n* is the number of genes and *m* is the number of expression values for a single gene. However, for the parallel implementation, the computation time is $O(\mathit{wm})$, where *w* is the *warp factor*. The warp factor is the ratio of the total number of blocks scheduled for the CUDA kernel to the warp size, where warp size is the number of threads that can run concurrently in the GPU. From [Fig. 4](#f0020){ref-type="fig"}, it can be stated that execution time doubles approximately as the value of *m* increases in GTOMm.

5. Conclusion {#s0055}
=============

The proposed PNME enables a faster way of constructing and analyzing gene-gene coexpression networks and extraction of highly-correlated modules through the use of a GPU. The extracted modules corresponding to metastasis and non-metastasis stages of breast cancer are validated using P-value.

Also, using the results obtained, the secondary genes which follow a common genetic pathway with causal genes in breast cancer have been identified and reported.
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